Effective Life Cycle Management (LCM) is a critical factor for successful commercialisation of pharmaceutical R&D output. This conference offers a unique opportunity to gain insight in the portfolio planning strategies of pharmaceutical companies.
Leading European life science experts from pharma/biotech business and research, contract research, IP and regulatory authorities will share their experience at the conference, which was tailored specifically for decision makers.
Moderation: Dr. Claire Skentelbery, Secretary General, European Biotechnology Foundation, Brussels
See Pictures of the conference here.
Programme |
||||
09:00 |
Welcome Address |
Marc Geleyn, |
||
Welcome Address |
Dr. Hans-Rainer Jaenichen, |
|||
|
Keynote |
Portfolio Management - The Art |
Roger Holdsworth, Director R&D Portfolio Management, UCB Pharma |
|
|
Strategy |
New Patents with Old Chemical Entities |
Dr. Chris Tanner, Chief Financial Officer, Cosmo Pharmaceuticals S.p.A. |
|
|
Strategy |
Customer Value Integration: |
Brigitte Reutter-Härle, Director Corporate Marketing, Vetter Pharma Intl. |
|
10:30 |
Coffee Break |
|||
11:00 |
Intellectual Property |
Patent Term Extension in Europe |
Dr. Christian Kilger, Patent Attorney, Vossius & Partner |
|
|
Intellectual Property |
The Goings in Big Pharma |
Dr. Christof Bull, Director, |
|
|
Intellectual Property |
Life Cycle Management |
Dr. Jürgen Schneider, Global Senior Director IP & Letigation, Qiagen |
|
12:30 |
Lunch |
|||
13:30 |
Optimisation |
Me-betters – HESylation: Optimisation of Protein Drugs |
Dr. Peter Vorstheim, Senior Vice President, Fresenius Kabi |
|
|
Pharma |
Multiple Sclerosis – The Rebif Life Cycle Story |
Dr. Reinoud Driebergen, Global Product Team Leader Rebif, Merck-Serono |
|
|
Advanced Therapies |
The ChondroCelect Experience |
Gil Beyen, CEO, TiGenix N.V. |
|
15:00 |
Coffee Break |
|||
15:30 |
Politics |
Reimbursement - The Payors View |
PD Dr. med. Matthias Perleth, Gemeinsamer Bundesausschuss |
|
|
Strategy |
Market Modelling |
Dr. Michael Motz, Director Global Business Development, Roche Pharma Partnering |
|
|
Discussion/Wrap-up |
Avoiding the Patent Cliff – Lessons Learned |
Dr. Claire Skentelbery, Secretary General, |
|
17:00 |
Networking Cocktail reception |
|||
When:
February 19th 2010, 9.00-17.00
Where:
Belgian Embassy, Jägerstrasse 52-53, 10117 Berlin, Germany [map]
Contact and further information:
Sabine Kuske (Registration)
+49 (0)30 26 49 21-48
events@biocom.de